Search results
Results from the WOW.Com Content Network
This is a list of investigational autism and pervasive developmental disorder drugs, or drugs that are currently under development for clinical use in the treatment of autistic spectrum disorders and/or other pervasive developmental disorders but are not yet approved.
Aribit (Aripiprazole) tablets. Aripiprazole, sold under the brand name Abilify, among others, is an atypical antipsychotic [14] primarily used in the treatment of schizophrenia, bipolar disorder, and irritability associated with autism spectrum disorder; [14] other uses include as an add-on treatment for major depressive disorder and tic disorders. [14]
The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, commonly called the Beers List, [1] are guidelines published by the American Geriatrics Society (AGS) for healthcare professionals to help improve the safety of prescribing medications for adults 65 years and older in all except palliative settings.
As an adult with autism, Dr. Kerry Magro fields at least 100 messages a month from parents whose children are the autism spectrum. ... It took 18 months for them to receive a formal diagnosis for ...
A box of Rispolept (Risperidone) tablets. Risperidone, sold under the brand name Risperdal among others, is an atypical antipsychotic [2] used to treat schizophrenia and bipolar disorder, [2] as well as aggressive and self-injurious behaviors associated with autism spectrum disorder. [9]
Antipsychotic abuse refers to the non-medical or inappropriate use of antipsychotic medications for purposes other than their intended therapeutic use. Antipsychotics, also known as neuroleptics, are a class of medications primarily used in treating psychiatric disorders such as schizophrenia, bipolar disorder, and certain types of depression.
Levetiracetam has not been found to be useful for treatment of neuropathic pain, [26] nor for treatment of essential tremors. [27] Levetiracetam has not been found to be useful for treating all developmental disorders within the autism spectrum; [28] [29] studies have only proven to be an effective treatment for partial, myoclonic, or tonic-clonic seizures associated with autism spectrum disorder.
In a study conducted between 2008 and 2012, 22.5% of children aged 7–17 in day programs for eating disorder treatment were diagnosed with ARFID. [40] In a 2021 study ARFID also has a high comorbidity with autism spectrum disorder (ASD), with up to 17% of adults with ASD at risk of developing disordered eating, with modest evidence for ...